Skip to content

Emotional Awareness and Expression Therapy for Prediabetes

Examining the Effect of a Novel Stress Reduction Intervention no the Control of Prediabetes: A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05344196
Enrollment
16
Registered
2022-04-25
Start date
2022-03-01
Completion date
2022-12-15
Last updated
2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PreDiabetes

Keywords

Stress reduction, Emotional Awareness and Expression Therapy

Brief summary

This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.

Detailed description

Prediabetes is a clinical condition in which hemoglobin A1C is between 5.6 and 6.4, and is usually associated with being overweight, poor diet, limited exercise, and psychological stress. This condition develops in to Type II diabetes in many people, and interventions to prevent such progression are needed. Because stress can directly negative impact blood glucose metabolism and can indirectly affect it through unhealthy behaviors (e.g., diet, exercise), it may be possible to reduce stress and improve clinical outcomes. Although most stress management approaches help people to calm their physiology and reduce their negative emotions, another approach to stress treatment is to help people disclose emotionally difficult experiences, become aware of and express their emotions, and change interpersonal relationships by becoming more assertive as well as more open/connected. Emotional Awareness and Expression Therapy (EAET) is an approach to stress reduction that uses these principles and it has been shown to be effective for somatic symptom disorders like chronic pain. In this study, we will adapt EAET to the prediabetes context and test its feasibility, acceptability and initial efficacy.

Interventions

BEHAVIORALModified EAET for prediabetes

Attempts to reduce stress and improve health behavior by engaging in emotional awareness and expression leading to changes in interpersonal relationships and health behavior

Sponsors

Wayne State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Several cohorts of people with prediabetes will be given the treatment and tracked with respect to outcomes from before to after treatment and follow-up

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Affiliated with Wayne State University (faculty, staff, student, or family member/friend thereof) * HbA1C value of 5.7% to 6.4% * overweight or obese (≥25 kg/m2) Also, if over ≥ 18 and \< 45 years of age must have at least one of the following: a) physical inactivity, b) close family history of diabetes, c) history of hyperlipidemia, d) history of hypertension, e) history of gestational diabetes, and/or f) from high risk race groups (e.g., African American, Latino, Native American, and pacific Islander).

Exclusion criteria

* Confirmed history of Type 2 Diabetes * have prediabetes being treated pharmacologically * pregnant * taking medications that affect blood glucose (e.g., corticosteroids) * chronic depression or major psychotic disorder * any comorbidities that limit survival or ability to tolerate the intervention (Cushing's, cancer treatment, asthma with inhaled corticosteroids, unstable CAD or MI in last 6 months, CHF, COPD requiring oxygen, chronic kidney disease)

Design outcomes

Primary

MeasureTime frameDescription
HbA1cChange from baseline to 3-month follow-up and 6-month follow-upHemoglobin A1c from venous blood
C-peptideChange from baseline to 3-month follow-up and 6-month follow-upvenous blood surrogate marker of insulin levels

Secondary

MeasureTime frameDescription
Perceived Stress ScaleChange from baseline to 3-month follow-up and 6-month follow-upPsychological stress (scores from 0 to 40; higher scores indicate more perceived stress)
Body mass indexChange from baseline to 3-month follow-up and 6-month follow-upMeasure of overweight / obesity
Health behaviorChange from baseline to 3-month follow-up and 6-month follow-upSelf-reported exercise and diet over the past week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026